Isostrychnopentamine, an Indolomonoterpenic Alkaloid from Strychnos usambarensis, with Potential Antitumor Activity against Apoptosis-Resistant Cancer Cells
Angenot, Luc ; Université de Liège - ULiège > Département de pharmacie > Pharmacognosie
Cao, Martine ; Université de Liège - ULiège > Département de pharmacie > Pharmacognosie
Kiss, Robert
Van Damme, Marc
Frederich, Michel ; Université de Liège - ULiège > Département de pharmacie > Pharmacognosie
Language :
English
Title :
Isostrychnopentamine, an Indolomonoterpenic Alkaloid from Strychnos usambarensis, with Potential Antitumor Activity against Apoptosis-Resistant Cancer Cells
Savage P, Stebbing J, Bower M and Crook T: Why does cytotoxic chemotherapy cure only some cancers? Nat Clin Pract Oncol 6: 43-52, 2009.
Wilson TR, Johnston PG and Longley DB: Anti-apoptotic mechanisms of drug resistance in cancer. Curr Cancer Drug Targets 9: 307-319, 2009.
Simpson CD, Anyiwe K and Schimmer AD: Anoikis resistance and tumor metastasis. Cancer Lett 272: 177-185, 2008.
Cragg GM, Grothaus PG and Newman DJ: Impact of natural products on developing new anti-cancer agents. Chem Rev 109: 3012-3043, 2009.
Frederich M, Hayette MP, Tits M, De Mol P and Angenot L: In vitro activities of Strychnos alkaloids and extracts against Plasmodium falciparum. Antimicrob Agents Chemother 43: 2328-2331, 1999.
Angenot L, Coune C and Tits M: Nouveaux alcaloïdes des feuilles du Strychnos usambarensis. J Pharm Beg 33: 11-23, 1978.
Tavernier D, Zhang W, Angenot L, Chierici-Tits M and Leclercq J: The structure of isostrychnopentamine, a bisindole monoterpene alkaloid from Strychnos usambarensis. Phytochemistry 26: 557-560, 1987.
Frédérich M, Tits M, Goffin E, Philippe G, Grellier P, De Mol P, Hayette MP and Angenot L: In vitro and in vivo antimalarial properties of isostrychnopentamine, an indolomonoterpenic alkaloid from Strychnos usambarensis. Planta Med 70: 520-525, 2004.
Frédérich M, Bentires-Alj M, Tits M, Angenot L, Greimers R, Gielen J, Bours V and Merville MP: Isostrychnopentamine, an indolomonoterpenic alkaloid from Strychnos usambarensis, induces cell cycle arrest and apoptosis in human colon cancer cells. J Pharmacol Exp Ther 304: 1103-1110, 2003.
Ceruti S, Mazzola A and Abbracchio MP: Resistance of human astrocytoma cells to apoptosis induced by mitochondria-damaging agents: possible implications for anticancer therapy. J Pharmacol Exp Ther 314: 825-837, 2005.
Lefranc F, Brotchi J and Kiss R: Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 23: 2411-2422, 2005.
Sarkaria JN, Kitange GJ, James CD, Plummer R, Calvert H, Weller M and Wick W: Mechanisms of chemoresistance to alkylating agents in malignant glioma. Clin Cancer Res 14: 2900-2908, 2008.
Mathieu A, Remmelink M, D'Haene N, Penant S, Gaussin JF, van Ginckel R, Darro F, Kiss R and Salmon I: Development of a chemoresistant orthotopic human non-small cell lung carcinoma model in nude mice: analyses of tumor heterogeneity in relation to the immunohistochemical levels of expression of cyclooxygenase-2, ornithine decarboxylase, lung-related resistance protein, prostaglandin E synthetase, and glutathione-S-transferase-alpha (GST)-alpha, GSY-mu and GST-pi. Cancer 101: 1908-1918, 2004.
Fenell DA: Caspase regulation in non-small cell lung cancer and its potential for therapeutic exploitation. Clin Cancer Res 11: 2097-2105, 2005.
Dumont P, Ingrassia L, Rouzeau S, Ribaucour F, Thomas S, Roland I, Darro F, Lefranc F and Kiss R: The Amaryllidaceae isocarbostyril narciclasine induces apoptosis by activation of the death receptor and/or mitochondrial pathways in cancer cells but not in normal fibroblasts. Neoplasia 9: 766-776, 2007.
Mijatovic T, van Quaquebeke E, Delest B, Debeir O, Darro F and Kiss R: Cardiotonic steroids on the road to anti-cancer therapy. Biochim Biophys Acta 1776: 32-57, 2007.
Lefranc F, Mijatovic T, Kondo Y, Sauvage S, Roland I, Debeir O, Krstic D, Vasic V, Gailly P, Kondo S, Blanco G and Kiss R: Targeting the alpha-1 subunit of the sodium pump to combat glioblastoma cells. Neurosurgery 62: 211-222, 2008.
Ingrassia L, Lefranc F, Dewelle J, Pottier L, Mathieu V, Spiegl-Kreinecker S, Sauvage S, El Yazidi M, Dehoux M, Berger W, van Quaquebeke E and Kiss R: Structure-activity relationship analysis of novel derivatives of narciclasine (an Amaryllidaceae isocarbostyril derivative) as potential anticancer agents. J Med Chem 52: 1110-1114, 2009.
Mijatovic T, Mathieu V, Gaussin JF, De Nève N, Ribaucour F, van Quaquebeke E, Dumont P, Darro F and Kiss R: Cardenolideinduced lysosomal membrane permeabilization demonstrates therapeutic benefits in experimental human non-small cell lung cancers. Neoplasia 5: 402-412, 2006.
De Hauwer C, Camby I, Darro F, Migeotte I, Decaestecker C, Verbeek C, Danguy A, Pasteels JL, Brotchi J, Salmon I, van Ham P and Kiss R: Gastrin inhibits motility, decreases cell death levels and increases proliferation in human glioblastoma cell lines. J Neurobiol 37: 373-382, 1998.
Debeir O, Van Ham P, Kiss R and Decaestecker C: Tracking of migrating cells under phase-contrast videomicroscopy with combined mean-shift processes. IEEE Trans Med Imaging 24: 697-711, 2005.
Lefranc F, Sauvage S, Van Goietsenoven G, Mégalizzi V, Lamoral-Theys D, Debeir O, Spiegl-Kreinecker S, Berger W, Mathieu V, Decaestecker C and Kiss R: Narciclasine, a plant growth regulator, activates Rho and stress fibers in glioblastoma cells. Mol Cancer Ther 8: 1739-1750, 2009.
Branle F, Lefranc F, Camby I, Jeuken J, Geurts-Moespot A, Sprenger S, Sweep F, Kiss R and Salmon I: Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy. Cancer 95: 641-655, 2002.
Palozza P, Sestito R, Picci N, Lanza P, Monego G and Ranelletti FO: The sensitivity to beta-carotene growth-inhibitory and proapoptotic effects is regulated by caveolin-1 expression in human colon and prostate cancer cells. Carcinogenesis 29: 2153-2161, 2008.
Hu CM and Chang ZF: Synthetic lethality by lentiviral short hairpin RNA silencing of thymidylate kinase and doxorubicin in colon cancer cells regardless of the p53 status. Cancer Res 68: 2831-2840, 2008.
De Berardinis RJ, Sayed N, Ditsworth D and Thompson CB: Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev 18: 54-61, 2008.
Kondoh H: Cellular life span and the Warburg effect. Exp Cell Res 314: 1923-1928, 2008.
Samudio I, Fiegl M and Andreeff M: Mitochondrial uncoupling and the Warburg effect: Molecular basis for the reprogramming of cancer cell metabolism. Cancer Res 69: 2163-2166, 2009.
Shanmugam M, McBrayer SK, Qian J, Raikoff K, Avram MJ, Singhal S, Gandhi V, Schumacker PT, Krett NL and Rosen ST: Targeting glucose consumption and autophagy in myeloma with the novel nucleoside analogue 8-amino-adenosine. J Biol Chem (In press).
Gnoula C, Mégalizzi V, De Nève N, Sauvage S, Ribaucour F, Guissou P, Duez P, Dubois J, Ingrassia L, Lefranc F, Kiss R and Mijatovic T: Balanitin-6 and -7: Diosgenyl saponins isolated from Balanites aegyptiaca Del. display significant anti-tumor activity in vitro and in vivo. Int J Oncol 32: 5-15, 2008.